aTyr Pharma, Inc. (ATYR)

aTyr Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Cash & Equivalents	16.16	10.01	10.74	6.15	17.22	10.36	11.06	11.46	6.81	6.81	22.54	9.79	12.31	20.69	9.98	18.36	8.48	8.32	2.34	59.74
Short-Term Investments	41.26	56.51	67.94	84.05	63.13	65.99	61.07	54.53	71.68	77.69	75.62	92.34	96.27	93.7	56.17	59.02	80.07	90.34	105.58	56.61
Cash & Short-Term Investments	57.42	66.51	78.69	90.2	80.35	76.35	72.13	65.99	78.48	84.5	98.17	102.13	108.58	114.39	66.15	77.37	88.55	98.67	107.91	116.35
Cash Growth (YoY)	-28.54%	-12.88%	9.10%	36.70%	2.38%	-9.64%	-26.53%	-35.39%	-27.72%	-26.13%	48.41%	32.00%	22.62%	15.93%	-38.70%	-33.50%	100.98%	94.85%	240.53%	221.90%
Other Receivables	0.43	0.48	0.87	1.04	0.5	0.99	1.74	1.83	1.63	2.48	2.44	2.09	1.29	1.63	11.78	0.87	0.43	0.43	0.44	0.13
Receivables	0.43	0.48	0.87	1.04	0.5	0.99	1.74	1.83	1.63	2.48	2.44	2.09	1.29	1.63	11.78	0.87	0.43	0.43	0.44	0.13
Prepaid Expenses	0.52	0.59	0.68	1.77	6.65	5.93	8.09	8.5	10.19	9.94	2.39	3.08	4.56	3.44	2.95	6.39	4.38	4.03	5.22	5.09
Total Current Assets	58.36	67.58	80.24	93.01	87.49	83.27	81.95	76.32	90.3	96.92	102.99	107.3	114.43	119.45	80.87	84.63	93.36	103.12	113.57	121.57
Property, Plant & Equipment	9.78	10.13	10.38	10.78	11.1	11.48	11.86	12.24	12.62	12.99	14.05	14.25	14.83	14.06	11.56	9.01	1.75	1.48	1.81	2.19
Other Long-Term Assets	1.69	1.95	2.38	2.86	2.94	2.5	3.02	3.06	3.03	3.34	3.62	3.52	3.49	3.33	3.36	2.41	0.91	0.18	0.16	0.16
Total Assets	69.83	79.65	93	106.65	101.53	97.25	96.83	91.62	105.94	113.25	120.65	125.07	132.75	136.84	95.79	96.06	96.02	104.78	115.54	123.92

Liabilities

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Accounts Payable	3.24	2.76	3.89	4.06	3.88	1.53	4.32	3.95	1.26	4.89	3.53	2.04	0.52	3.97	3.11	3.13	1.67	1.56	1.03	0.9
Accrued Expenses	6.69	7.46	9.79	10.19	10.32	7.86	9.39	8.96	9.41	9.95	11.56	9.61	10.79	8.89	9.86	7.27	6.61	3.69	4	3.97
Current Portion of Leases	1.46	1.49	1.47	1.43	1.33	1.29	1.25	1.21	1.17	1.14	1.33	1.23	1.06	0.8	0.89	0.82	0.98	1.01	0.98	0.95
Total Current Liabilities	11.4	11.7	15.15	15.68	15.53	10.68	14.97	14.12	11.84	15.98	16.42	12.88	12.37	13.65	13.86	11.21	9.26	6.27	6.01	5.82
Long-Term Leases	9.84	10.21	10.57	10.93	11.35	11.7	12.03	12.36	12.68	12.99	13.77	13.99	14.33	13.49	10.64	7.84	0.3	0.13	0.4	0.66
Total Liabilities	21.23	21.91	25.72	26.61	26.88	22.38	27	26.48	24.52	28.97	30.18	26.87	26.7	27.14	24.5	19.05	9.56	6.4	6.41	6.48

Shareholders' Equity

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Common Stock	0.1	0.1	0.1	0.1	0.09	0.09	0.08	0.08	0.08	0.07	0.06	0.06	0.06	0.05	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-In Capital	676.02	674.86	673.55	672.34	641.28	621.95	602.02	582.29	581.52	568.07	558.69	551.89	548.44	539.66	489.5	487.94	484.29	483.73	481.83	481.39
Retained Earnings	-627.26	-616.96	-606.16	-592.2	-566.46	-546.93	-532.05	-517.08	-499.82	-483.51	-468.02	-453.26	-441.92	-429.59	-417.63	-410.11	-396.87	-384.45	-372.3	-363.74
Comprehensive Income & Other	-0.07	-0.07	-0.01	-0	-0.08	-0.07	-0.04	0.04	-0.17	-0.16	-0.07	-0.29	-0.33	-0.25	-0.43	-0.67	-0.81	-0.76	-0.26	-0.07
Total Common Equity	48.79	57.93	67.48	80.24	74.85	75.05	70.02	65.33	81.61	84.47	90.66	98.39	106.24	109.88	71.46	77.18	86.64	98.55	109.3	117.61
Minority Interest	-0.19	-0.19	-0.19	-0.19	-0.19	-0.19	-0.19	-0.19	-0.18	-0.18	-0.19	-0.19	-0.19	-0.18	-0.18	-0.18	-0.18	-0.18	-0.18	-0.17
Shareholders' Equity	48.59	57.74	67.29	80.04	74.66	74.86	69.83	65.14	81.42	84.28	90.47	98.2	106.05	109.7	71.28	77.01	86.46	98.37	109.13	117.44
Total Liabilities & Equity	69.83	79.65	93	106.65	101.53	97.25	96.83	91.62	105.94	113.25	120.65	125.07	132.75	136.84	95.79	96.06	96.02	104.78	115.54	123.92

Additional Metrics

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Total Debt	11.3	11.7	12.03	12.36	12.68	12.99	13.28	13.57	13.85	14.13	15.1	15.22	15.39	14.29	11.53	8.65	1.27	1.15	1.38	1.61
Net Cash (Debt)	46.12	54.81	66.65	77.84	67.67	63.36	58.84	52.42	64.63	70.37	83.07	86.91	93.19	100.1	54.61	68.72	87.28	97.52	106.53	114.75
Net Cash Growth (YoY)	-31.85%	-13.49%	13.28%	48.51%	4.70%	-9.96%	-29.17%	-39.69%	-30.65%	-29.70%	52.11%	26.47%	6.77%	2.64%	-48.74%	-40.11%	106.65%	100.65%	261.74%	274.43%
Net Cash Per Share	18.81	22.36	27.20	32.05	30.03	29.30	28.45	27.66	35.76	42.60	56.07	60.06	67.60	95.56	75.03	95.90	124.40	140.23	153.33	252.76
Filing Date Shares Outstanding	2.45	2.45	2.45	2.45	2.45	2.23	2.22	2.1	1.89	1.73	1.69	1.46	1.43	1.36	1.33	0.73	0.72	0.7	0.69	0.69
Total Common Shares Outstanding	2.45	2.45	2.45	2.45	2.32	2.23	2.1	1.9	1.89	1.71	1.58	1.46	1.43	1.33	0.74	0.73	0.7	0.7	0.69	0.69
Working Capital	46.97	55.88	65.09	77.34	71.96	72.59	66.99	62.2	78.46	80.94	86.58	94.42	102.06	105.79	67.01	73.42	84.1	96.85	107.56	115.75
Book Value Per Share	19.90	23.63	27.53	32.75	32.24	33.73	33.33	34.47	43.07	49.43	57.30	67.21	74.49	82.40	96.91	106.43	123.20	140.50	157.31	169.28
Tangible Book Value	48.79	57.93	67.48	80.24	74.85	75.05	70.02	65.33	81.61	84.47	90.66	98.39	106.24	109.88	71.46	77.18	86.64	98.55	109.3	117.61
Tangible Book Value Per Share	19.90	23.63	27.53	32.75	32.24	33.73	33.33	34.47	43.07	49.43	57.30	67.21	74.49	82.40	96.91	106.43	123.20	140.50	157.31	169.28
Machinery	-	-	3.44	-	-	-	3.74	-	-	-	4.5	-	-	-	5	-	-	-	5	-
Leasehold Improvements	-	-	5.65	-	-	-	5.65	-	-	-	5.65	-	-	-	4.41	-	-	-	1.7	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error